RSPO3 and malignant colon neoplasm: The demonstration that RSPO3 is a driver of intestinal cancer [25], and the fact that LGR5 is a WNT/β-catenin signaling target [17] urged us to explore a possible relationship between RSPO3 and LGR5 as well as WNT5A signaling in colon cancer tissues.